Shree Ram Singh

4.4k total citations
124 papers, 3.2k citations indexed

About

Shree Ram Singh is a scholar working on Biotechnology, Molecular Biology and Genetics. According to data from OpenAlex, Shree Ram Singh has authored 124 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Biotechnology, 43 papers in Molecular Biology and 40 papers in Genetics. Recurrent topics in Shree Ram Singh's work include Cancer Research and Treatments (50 papers), Virus-based gene therapy research (29 papers) and Nanoplatforms for cancer theranostics (23 papers). Shree Ram Singh is often cited by papers focused on Cancer Research and Treatments (50 papers), Virus-based gene therapy research (29 papers) and Nanoplatforms for cancer theranostics (23 papers). Shree Ram Singh collaborates with scholars based in United States, Japan and China. Shree Ram Singh's co-authors include Steven X. Hou, Robert M. Hoffman, Yiyong Wei, Michael Bouvet, Takashi Higuchi, Kentaro Miyake, Wei Liu, Bashisth N. Singh, Kentaro Igarashi and Xiankun Zeng and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Shree Ram Singh

124 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shree Ram Singh United States	33	1.3k	667	665	659	638	124	3.2k
James C. Garbe United States	32	1.9k 1.4×	137 0.2×	471 0.7×	287 0.4×	827 1.3×	55	2.8k
Christian Beauséjour Canada	25	5.1k 3.9×	216 0.3×	571 0.9×	1.2k 1.8×	998 1.6×	57	7.5k
Ruben van Boxtel Netherlands	30	2.7k 2.1×	205 0.3×	1.4k 2.1×	700 1.1×	1.7k 2.7×	84	5.0k
Ariel A. Avilion United States	15	4.3k 3.3×	619 0.9×	365 0.5×	878 1.3×	457 0.7×	21	6.4k
Steven E. Artandi United States	41	5.3k 4.1×	593 0.9×	570 0.9×	649 1.0×	966 1.5×	70	7.9k
Esther Danenberg Netherlands	9	3.4k 2.6×	171 0.3×	600 0.9×	732 1.1×	2.0k 3.1×	9	5.1k
Ralph Meuwissen Netherlands	19	2.6k 2.0×	245 0.4×	1.0k 1.5×	428 0.6×	1.4k 2.3×	25	4.1k
Sander van den Heuvel United States	33	4.2k 3.2×	110 0.2×	378 0.6×	537 0.8×	1.4k 2.3×	59	5.9k
Xiang‐Fu Wu China	17	3.1k 2.4×	75 0.1×	658 1.0×	356 0.5×	550 0.9×	110	4.1k
Elena Dellambra Italy	28	1.9k 1.4×	128 0.2×	277 0.4×	694 1.1×	606 0.9×	67	3.9k

Countries citing papers authored by Shree Ram Singh

Since Specialization

Citations

This map shows the geographic impact of Shree Ram Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shree Ram Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shree Ram Singh more than expected).

Fields of papers citing papers by Shree Ram Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shree Ram Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shree Ram Singh. The network helps show where Shree Ram Singh may publish in the future.

Co-authorship network of co-authors of Shree Ram Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Shree Ram Singh. A scholar is included among the top collaborators of Shree Ram Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shree Ram Singh. Shree Ram Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamamoto, Jun, Kentaro Miyake, Qinghong Han, et al.. (2020). Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model. Cancer Letters. 492. 174–184. 32 indexed citations

Choi, Eun A, et al.. (2019). A pharmacogenomic analysis using L1000CDS2 identifies BX-795 as a potential anticancer drug for primary pancreatic ductal adenocarcinoma cells. Cancer Letters. 465. 82–93. 12 indexed citations

Higuchi, Takashi, Kentaro Miyake, Hiromichi Oshiro, et al.. (2019). Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model. Biochemical and Biophysical Research Communications. 513(2). 326–331. 35 indexed citations

Zhang, Zhiying, Kaiwen Hu, Tasuku Kiyuna, et al.. (2019). A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma. Pharmacological Research. 142. 169–175. 18 indexed citations

Higuchi, Takashi, Qinghong Han, Kentaro Miyake, et al.. (2019). Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model. Biochemical and Biophysical Research Communications. 523(1). 135–139. 26 indexed citations

Obara, Koya, Sumiyuki Mii, Yuko Hamada, et al.. (2019). Hair-follicle-associated pluripotent stem cells derived from cryopreserved intact human hair follicles sustain multilineage differentiation potential. Scientific Reports. 9(1). 9326–9326. 19 indexed citations

Higuchi, Takashi, Kentaro Miyake, Norihiko Sugisawa, et al.. (2019). Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model. Cancer Letters. 451. 122–127. 12 indexed citations

Sugisawa, Norihiko, Kentaro Miyake, Takashi Higuchi, et al.. (2019). Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy. Anticancer Research. 39(10). 5339–5344. 8 indexed citations

Miyake, Kentaro, Tasuku Kiyuna, Kei Kawaguchi, et al.. (2019). Regorafenib regressed a doxorubicin-resistant Ewing’s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model. Cancer Chemotherapy and Pharmacology. 83(5). 809–815. 18 indexed citations

10.

Hiroshima, Yukihiko, Rika Kasajima, Yayoi Kimura, et al.. (2019). Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters. 469. 217–227. 18 indexed citations

11.

Kawaguchi, Kei, Kentaro Miyake, Qinghong Han, et al.. (2018). Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. Cancer Letters. 432. 251–259. 71 indexed citations

12.

Obara, Koya, Sumiyuki Mii, Yuko Hamada, et al.. (2018). Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Encapsulated on Polyvinylidene Fluoride Membranes (PFM) Promote Functional Recovery from Spinal Cord Injury. Stem Cell Reviews and Reports. 15(1). 59–66. 11 indexed citations

13.

Igarashi, Kentaro, Kei Kawaguchi, Tasuku Kiyuna, et al.. (2018). Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models. Biochemical and Biophysical Research Communications. 497(4). 1055–1061. 26 indexed citations

14.

Kawaguchi, Kei, Kentaro Igarashi, Kentaro Miyake, et al.. (2018). Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models. Journal of drug targeting. 27(2). 211–216. 15 indexed citations

15.

Jung, Sun-Young, Eunji Lee, Jong Won Lee, et al.. (2018). Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model. Cancer Letters. 428. 127–138. 15 indexed citations

16.

Liu, Ying, Brian H. K. Chan, Hanhan Liu, et al.. (2016). Whole-animal genome-wide RNAi screen identifies networks regulating male germline stem cells in Drosophila. Nature Communications. 7(1). 12149–12149. 19 indexed citations

17.

Seol, Hyang Sook, Sang Eun Lee, Joon Seon Song, et al.. (2016). Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production. Cancer Letters. 382(2). 157–165. 34 indexed citations

18.

Singh, Shree Ram, Ying Liu, Jiang‐Sha Zhao, Xiankun Zeng, & Steven X. Hou. (2016). The novel tumour suppressor Madm regulates stem cell competition in the Drosophila testis. Nature Communications. 7(1). 10473–10473. 25 indexed citations

19.

Seol, Hyang Sook, Sang Eun Lee, Joon Seon Song, et al.. (2015). Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1. Cancer Letters. 372(1). 24–35. 54 indexed citations

20.

Singh, Shree Ram & Bashisth N. Singh. (2000). Male Remating in Drosophila ananassae: Evidence for Interstrain Variation in Remating Time and Shorter Duration of Copulation during Second Mating. ZOOLOGICAL SCIENCE. 17(3). 389–393. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact